INVESTIGATOR TEAM MEMBERS
Role: Lead of Stage 2
PARTNERSHIPS DIRECTOR, BUSARA CENTER
DR MONICA KUTEESA
YVONNE WANGŨI MACHIRA
DIRECTOR, SOCIO-BEHAVIORAL RESEARCH, IAVI
Role: Project Manager; member of PMG
DR MATTHEW QUAIFE
ASSOCIATE PROFESSOR, HEALTH ECONOMICS, LSHTM
Role: Health Economist
LECTURER & CLINICAL RESEARCHER, KAVI-ICR
DR YUNIA MAYANJA
PROJECT LEAD, EPIDEMIOLOGY & PREVENTION, MRC/UVRI & LSHTM UGANDA RESEARCH UNIT
Role: Co-investigator; MUL study team lead
DR MELISSA NEUMAN
ASSISTANT PROFESSOR, EPIDEMIOLOGY, LSHTM
BUSARA CENTER FOR BEHAVIORAL ECONOMICS
Francis is the Vice President of the Busara Center for Behavioral Economics where he manages the projects division. His work focuses on sexual reproductive health as well as digital financial services. He has over 10 years of experience in global development and has partnered with various organisations including Jhpiego, JnJ, RTI, Safaricom, NCBA, KCB. He graduated from Vassar College with a degree in economics and political science.
Role in UPTAKE: Behavioral Science Lead; member of the PMG
DR ANATOLI KAMALI
AFRICA FIELD PROGRAMS DIRECTOR,
Anatoli Kamali is responsible for external relations activities and leading the representation of the USAID Cooperative Agreement (ADVANCE) mission to high level Africa organizations and policy makers. He oversees scientific implementation and outcomes of the Cooperative Agreement field programs and linked programming in Africa, including maintaining and growing scientific collaborations with Africa Clinical Research Centres Leaderships and local and international partners. He leads the development and successful execution of high level partnerships, and providing guidance to the community engagement, policy, advocacy, and research preparedness activities of the Cooperative Agreement work in Africa; and facilitates the dissemination of research outputs. Prior to IAVI, Kamali was the deputy director and head of the HIV Epidemiology and Prevention Research Program at the Medical Research Council/Uganda Virus Research Institute Unit on AIDS. Kamali has also served as a member of the International Data and Safety Monitoring Board of the Division of AIDS at the U.S. National Institute of Allergy and Infectious Diseases, as temporary advisor on sexual and reproductive health to the World Health Organization, and he was a member of the U.K. Microbicides Development Programme that conducted a Phase III vaginal microbicide trial. He holds an M.B.Ch.B. from Makerere University in Kampala, Uganda, an M.Sc. from the London School of Hygiene and Tropical Medicine, where he is an honorary professor, and a Ph.D. from City, University of London.
Role in UPTAKE: Principle Investigator and Project Coordinator; member of the PMG
PROFESSOR OMU ANZALA
KAVI-INSTITUTE OF CLINICAL RESEARCH
Omu Anzala is a professor of virology and immunology and director of the KAVI-Institute of Clinical Research (KAVI-ICR) at the University of Nairobi. He has decades of experience in the field of HIV vaccine research and played a key role in the establishment of KAVI-ICR. Anzala is a member of the African Vaccine Manufacturing Initiative (AVMI), the Kenya national Vaccine Safety Advisory Committee, the African Advisory Committee on Vaccine Safety (AAVS), and the Kenya National COVID-19 Task Force. Further, he is team lead of the University of Nairobi COVID-19 Modelling Committee and a board member and director of the Welter Sisulu Foundation. A graduate of the University of Nairobi’s Medical School, he received his PhD at the University of Manitoba, Canada, and did his postdoctoral work in molecular immunology at Oxford University. Anzala holds a Diploma in Epidemiology from Tufts University and several professional certifications, including Advanced Good Laboratory Practice (GLP), Ethical Aspects of Clinical Research, Experimental Epidemiology, and Bioethics.
Role in UPTAKE: KAVI-ICR Study Lead; member of the PMG
DR MITZY GAFOS
LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE
Dr Mitzy Gafos is a mixed methods social scientist in the Department of Global Health at LSHTM, where she focuses on HIV prevention research among affected communities in Eastern and Southern Africa, Asia, and Europe. Previously, Mitzy was a research director of the DFID funded STRIVE consortium which aimed to tackle the structural drivers of HIV focusing on gender and social norms, transactional sex, violence against women and girls, stigma and discrimination and alcohol and HIV risk. She has also worked in trials of vaginal microbicides, oral PrEP, HIV self-testing and therapeutic vaccines. Gafos also has a keen interest in Patient and Public Involvement (PPI) in research.
Role in UPTAKE: LSHTM Study Lead; member of the PMG
PROFESSOR PONTIANO KALEEBU
MRC/UVRI & LSHTM UGANDA RESEARCH UNIT
Professor Pontiano Kaleebu is the Director of the Uganda Virus Research Institute (UVRI) and of the MRC/UVRI and LSHTM Uganda Research Unit, where he heads the Pathogen Genomics, Phenotype and Immunity programme. He is a professor of immunovirology at the London School of Hygiene & Tropical Medicine, and was elected a Fellow of the Academy of Medical Sciences in 2020. His main research interest has been in understanding protective immune responses that could lead to the development of an HIV vaccine and he was one of the investigators in the first HIV vaccine trial conducted in Africa. He also leads the HIV drug resistance Technical Working Group in Uganda and his programme hosts the National HIV drug resistance reference laboratory.
Role in UPTAKE: MRC/UVRI & LSHTM Uganda Research Unit Study Lead